Lipid metabolic enzyme and pathway

Lipid metabolic enzymes and pathways" refers to a collective set of enzymes and the biochemical routes they mediate, responsible for the synthesis, modification, transport, storage, and breakdown of lipids in the body[1][2][4]. These enzymes include, but are not limited to, fatty acid synthases, elongases, desaturases, acyl-CoA synthetases, lipases, phospholipases, and others, operating within integrated networks such as fatty acid synthesis, β-oxidation, lipogenesis, lipolysis, and cholesterol metabolism pathways[1][4][2]. These processes are not mediated by a single molecular target or receptor but encompass extensive metabolic networks and regulatory nodes distributed across major organs, especially the liver, adipose tissue, muscle, and intestines[4][5]. Lipid metabolic pathways are essential for energy homeostasis, formation and remodeling of biological membranes, synthesis of signaling molecules (including lipid mediators like prostaglandins and leukotrienes[6]), and steroid hormone production. Dysregulation of one or more of these enzymes or pathways is implicated in numerous diseases, including metabolic syndrome, cardiovascular disease, obesity, diabetes, and some cancers[1][6]. The category does not correspond to a singular canonical target; thus, it is not appropriate to treat "lipid metabolic enzymes and pathways" as a druggable target in the conventional sense[1][4]. **Note:** - This entry is flagged as *is_incorrect: true* since "Lipid metabolic enzymes and pathways" is not a single molecular entity, receptor, or canonical drug target, but instead encompasses many enzymes and pathways. Structured downstream information should be derived at the level of individual enzymes or molecular targets within this group (e.g., HMG-CoA reductase, Lipoprotein lipase, Fatty acid synthase)[1][4]. - Most drugs and biomarkers listed interact with, or monitor, components within this system, not the entirety as a single target.

Other names

Lipid metabolismLipid metabolic pathwayLipid metabolic enzymesLipid processing enzymesFatty acid metabolic pathwaysFatty acid metabolic enzymes

Enzyme inhibition (e.g., HMG-CoA reductase inhibitors), Enzyme activation/modulation, Receptor agonism/antagonism, Lipid absorption blockage, Lipid transport modification